Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia

U

University of Indonesia (UI)

Status and phase

Completed
Phase 4

Conditions

Obesity, Adolescent
Oxidative Stress

Treatments

Drug: Placebo oral capsule
Drug: Vitamin E 400 UNT

Study type

Interventional

Funder types

Other

Identifiers

NCT03358524
001

Details and patient eligibility

About

This study evaluate supplementation of vitamin E (alpha-tocopherol) in obese adolescent. Half of the patient will receive vitamin E and the other half received placebo

Full description

One of obesity treatments that play important role is antioxidant diet. The effects of vitamin E supplementation as an antioxidant treatment in obese adolescent have not been concluded yet in Indonesia. The primary aim of this study is to observe oxidative stress biomarker (isoprostane) in obese teenagers who consume vitamin E for 2 months. The secondary aim is to observe their body mass index and lipid profile after supplementation The study is randomized, double blind, placebo controlled trial in design and employed a consecutive sampling technique to sample subjects of 70 obese adolescent age 14 - 18 in senior high schools Jakarta. Blood tests of lipid profile (total cholesterol, HDL, LDL, Triglyceride), fasting blood glucose, liver function (AST,ALT) and oxidative stress biomarker (isoprostane) were taken for every subject after done fasting for 12 hours. This study is a randomized allocation and double blind technique. subjects divided into two groups, which one group receiving treatment of vitamin E and other group receiving placebo. The dose and duration of vitamin E treatment is 400 IU per day for 2 months. At the end of treatment, all subjects had to run the same medical interview, physical examination and blood test.

Enrollment

69 patients

Sex

All

Ages

14 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Obesity BMI ≥ p95 (CDC growth curve)

Exclusion criteria

  • Consuming antioxidants drug regularly within recruiting time
  • Consuming Orlistat

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

69 participants in 2 patient groups, including a placebo group

Vitamin E 400 IU
Experimental group
Description:
Vitamin-E Capsule (alpha-tocopherol) 400 IU once per day orally for 8 weeks
Treatment:
Drug: Vitamin E 400 UNT
Placebo
Placebo Comparator group
Description:
Placebo capsule once per day orally for 8 weeks
Treatment:
Drug: Placebo oral capsule

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems